Efficacy and Safety of Immune Checkpoint Inhibitors (ICI) in Resectable Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis

被引：0
|
作者：
Xiao, T. [1 ]
Verma, S. [1 ]
Boldt, G. [1 ]
Rajeh, A. [1 ]
Breadner, D. [2 ]
Raphael, J. [3 ]
机构：
[1] Western Univ, London, ON, Canada
[2] LRCP, London, ON, Canada
[3] Western Univ, London Hlth Sci Ctr, London, ON, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
103
引用
收藏
页码：E6 / E6
页数：1
相关论文
共 50 条
  • [31] Association of clinical and molecular factors with immune checkpoint inhibitors efficacy in advanced non-small cell lung cancer:A systematic review and meta-analysis
    Li, F.
    Lv, Z.
    Mao, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1054 - S1054
  • [32] Association of clinical and molecular factors with immune checkpoint inhibitors efficacy in advanced non-small cell lung cancer: A systematic review and meta-analysis
    Li, F.
    Lv, Z.
    Mao, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S1574 - S1575
  • [33] Safety and efficacy of restarting immune checkpoint inhibitors in non-small cell lung cancer patients following immune-related adverse events: a systematic review and meta-analysis
    Tan, Kexin
    Wang, Aolin
    Zheng, Yumin
    Wang, Shuo
    Wang, Chao
    Li, Jia
    Lu, Xingyu
    Dong, Huijing
    Zheng, Jiabin
    Cui, Huijuan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, : 196 - 203
  • [34] Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysis
    Han, Yuelin
    Xiao, Xiangtian
    Qin, Tingting
    Yao, Shuxi
    Liu, Xinyue
    Feng, Yanqi
    Li, Zhou
    Li, Yiming
    Xia, Shu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [35] Efficacy and safety of different cycles of neoadjuvant immunotherapy in resectable non-small cell lung cancer: A systematic review and meta-analysis
    Ye, Linlin
    Liu, Yao
    Xiang, Xuan
    Wang, Zihao
    Wei, Xiaoshan
    Peng, Wenbei
    Zhang, Siyu
    Xue, Qianqian
    Zhou, Qiong
    HELIYON, 2024, 10 (11)
  • [36] Impact of KRAS mutations and subtypes on efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC)
    Mazieres, J.
    Tomasini, P.
    Lusque, A.
    Boucekine, M.
    Gautschi, O.
    Cortot, A. B.
    Couraud, S.
    Thai, A.
    Ng, T.
    Greillier, L.
    Veillon, R.
    Neal, J. W.
    Popat, S.
    Gounant, V.
    Mhanna, L.
    Drilon, A.
    Baron, J. Milia
    Barlesi, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S826 - S827
  • [37] Fatal Adverse Events Associated With Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Yu, Xiaolin
    Zhang, Xiaomei
    Yao, Ting
    Zhang, Ye
    Zhang, Yanxia
    FRONTIERS IN MEDICINE, 2021, 8
  • [38] Safety and Efficacy of Immune Checkpoint Inhibitors in Cancer Patients and Preexisting Autoimmune Disease: A Systematic Review and Meta-Analysis in Non-Small-Cell Lung Cancer
    Aung, Wint Yan
    Lee, Chung-Shien
    Morales, Jaclyn
    Rahman, Husneara
    Seetharamu, Nagashree
    CLINICAL LUNG CANCER, 2023, 24 (07) : 598 - 612
  • [39] Immune checkpoint inhibitors in the treatment of small cell lung cancer: A systematic review and meta-analysis
    Lee, P. W. P.
    Krishnan, N.
    Boldt, G.
    Lakkunarajah, S.
    Blanchette, P.
    Raphael, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1076 - S1076
  • [40] Thyroid Dysfunction in Non-Small Cell Lung Cancer With Immune Checkpoint Inhibitors: A Meta-Analysis
    Lin, Lanlan
    Yang, Fan
    Lin, Guofu
    Chen, Xiangqi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (02): : 210 - 218
12345